• English
    • Deutsch
  • English 
    • English
    • Deutsch
  • Login
View Item 
  •   Home
  • Universität Ulm / Medizin
  • Publikationsnachweise
  • View Item
  •   Home
  • Universität Ulm / Medizin
  • Publikationsnachweise
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Neoadjuvant paclitaxel/olaparib in comparison to paclitaxel/carboplatinum in patients with HER2-negative breast cancer and homologous recombination deficiency (GeparOLA study)

Erstveröffentlichung
2021
Authors
Fasching, P. A.
Link, T.
Hauke, J.
Seither, F.
Jackisch, C.
et al.
Wissenschaftlicher Artikel


Published in
Annals of Oncology ; 32 (2021), 1. - S. 49-57. - ISSN 0923-7534. - eISSN 1569-8041
Link to publication
https://dx.doi.org/10.1016/j.annonc.2020.10.471
Institutions
UKU. Klinik für Frauenheilkunde und Geburtshilfe
Subject headings
[Free subject headings]: PARP inhibitor | HER2-negative breast cancer | HRD | neoadjuvant therapy | olaparib | carboplatinum | PATHOLOGICAL COMPLETE RESPONSE | CHEMOTHERAPY | CARBOPLATIN | GEPARSIXTO | SURVIVAL | MUTATION
[DDC subject group]: DDC 610 / Medicine & health

Metadata
Show full item record

Policy | kiz service OPARU | Contact Us
Impressum | Privacy statement
 

 

Advanced Search

Browse

All of OPARUCommunities & CollectionsPersonsInstitutionsPublication typesUlm SerialsDewey Decimal ClassesEU projects UlmDFG projects UlmOther projects Ulm

My Account

LoginRegister

Statistics

View Usage Statistics

Policy | kiz service OPARU | Contact Us
Impressum | Privacy statement